AMPROLOGIX
Amprologix has been established to develop the work of Professor Mathew Upton. The company aims to introduce new classes of antibiotics to help tackle the threat of antimicrobial resistance. The first product from the company is expected to be a cream containing epidermicin, which can rapidly kill harmful bacteria, including MRSA, Streptococcus and Entercoccus at very low doses. Amprologix has already secured industry involvement through a partnership with world-leading biotechnology and synthetic biology company Ingenza.
AMPROLOGIX
Industry:
Biotechnology Pharmaceutical
Founded:
2018-01-01
Address:
Plymouth, Minnesota, United States
Country:
United States
Website Url:
http://www.amprologix.com
Status:
Active
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt WordPress Wordpress Plugins Nginx PHP
Similar Organizations
Investors List
Frontier IP Group plc
Frontier IP Group plc investment in Venture Round - Amprologix
Official Site Inspections
http://www.amprologix.com
- Host name: amprologix.com
- IP address: 87.106.36.242
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
